Michael Arzt, MD, investigated the use of ASV therapy in patients with TE-CSA and cardiovascular disease, finding it effective in reducing sleepiness and improving quality of life. It may be more ...
Breathing machines with adaptive servo-ventilation (ASV) did not improve survival or other clinical outcomes in patients with heart failure (HF) and reduced ejection fraction and sleep-disordered ...
On May 15, 2015, Respironics, Inc., a Philips business, provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea ...
There's a problem though. CPAP doesn't seem to improve CVD-related outcomes. In some cases, it's even harmful. Let's do a quick review. In 2005, the CANPAP study found CPAP didn't improve a composite ...
March 12, 2007 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a device intended to provide ventilatory support for patients with sleep apnea, a data management system for ...
Sleep apnea causes breathing to stop and start during sleep, leading to snoring and daytime sleepiness. Untreated sleep apnea may raise stroke, heart failure, and high blood pressure risk. Continuous ...
The gold standard for moderate to severe obstructive sleep apnea (OSA) is continuous positive airway pressure (CPAP) therapy. For a CPAP machine alone, it can cost anywhere from $500 to $1000 or more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results